{
  "prompt": {
    "guidelineId": "mp036-care-of-women-with-haemoglobinopathies-pdf",
    "fieldsProcessed": [
      "humanFriendlyName",
      "organisation",
      "yearProduced",
      "summary"
    ],
    "enhancedFields": 4,
    "contentLength": 1761
  },
  "response": "{\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Care Guidelines for Women with Haemoglobinopathies\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"RCOG\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"The text does not contain a publication year. If you have the year from another source, please provide it, and I can verify or extract it for you\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Care Guidelines for Women with Haemoglobinopathies** This protocol applies to childbearing women with haemoglobinopathies, with midwives and obstetricians responsible for its implementation. Key recommendations: - **Screening & Testing**: Pregnant women with haemoglobinopathies should be referred to the antenatal screening coordinator midwife, with partner testing offered after abnormal results. - **Thalassaemia**: Thalassaemia trait poses no risk, but major/intermedia cases require haematologist involvement due to increased maternal/fetal risks. - **Sickle Cell Disease**: Increased risk of crisis (third trimester), pre-eclampsia, and fetal growth restriction. Manage crises with IV hydration, analgesia, and obstetric/anesthetic referral. - **Labour**: No contraindication to normal obstetric practice; continuous fetal monitoring advised. - **Postnatal Care**: High risk for venous thromboembolism; consider low-molecular-weight heparin prophylaxis. Professional judgement should guide protocol application. Management ensures accessibility and regular review\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "endpoint": "enhanceGuidelineMetadata",
  "timestamp": "2025-06-18T22-44-10",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"guidelineId\": \"mp036-care-of-women-with-haemoglobinopathies-pdf\",\n  \"fieldsProcessed\": [\n    \"humanFriendlyName\",\n    \"organisation\",\n    \"yearProduced\",\n    \"summary\"\n  ],\n  \"enhancedFields\": 4,\n  \"contentLength\": 1761\n}\n\nA: {\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Care Guidelines for Women with Haemoglobinopathies\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"RCOG\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"The text does not contain a publication year. If you have the year from another source, please provide it, and I can verify or extract it for you\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Care Guidelines for Women with Haemoglobinopathies** This protocol applies to childbearing women with haemoglobinopathies, with midwives and obstetricians responsible for its implementation. Key recommendations: - **Screening & Testing**: Pregnant women with haemoglobinopathies should be referred to the antenatal screening coordinator midwife, with partner testing offered after abnormal results. - **Thalassaemia**: Thalassaemia trait poses no risk, but major/intermedia cases require haematologist involvement due to increased maternal/fetal risks. - **Sickle Cell Disease**: Increased risk of crisis (third trimester), pre-eclampsia, and fetal growth restriction. Manage crises with IV hydration, analgesia, and obstetric/anesthetic referral. - **Labour**: No contraindication to normal obstetric practice; continuous fetal monitoring advised. - **Postnatal Care**: High risk for venous thromboembolism; consider low-molecular-weight heparin prophylaxis. Professional judgement should guide protocol application. Management ensures accessibility and regular review\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": null
}